Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration’s national program Elizabeth M. Oliva, Melissa.

Slides:

Advertisements

Similar presentations

Daliah Heller, PhD, MPH Assistant Commissioner

Advertisements

Connexin Mutations in Skin Disease and Hearing Loss David P. Kelsell, Wei-Li Di, Mark J. Houseman The American Journal of Human Genetics Volume 68, Issue.

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.

Naloxone: Prescribing and Dispensing

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Overdose Prevention Pilot Project Cross Systems Collaboration. Naloxone Distribution In cooperation with LA Community Health Project June 4, 2014, VCBH,

Patient request for pharmacist counseling and satisfaction: Automated prescription delivery system versus regular pick-up counter Jan D. Hirsch, PhD Journal.

Peopling of Sahul: mtDNA Variation in Aboriginal Australian and Papua New Guinean Populations Alan J. Redd, Mark Stoneking The American Journal of Human.

Pharmacist Role in Naloxone Prescribing

An overdose Reduction PlaN

Effect of antibacterials on biofilms

Volume 17, Issue 5, Pages (May 2016)

Experiences from a national overdose prevention strategy: Nasal naloxone distribution and lessons learned Philipp Lobmaier, MD, PhD Norwegian Centre.

First Responder Naloxone Grant Webinar

Opioid Overdose Education and Naloxone Distribution for Clinicians

Joshua H. Atkins, MD, PhD, Christopher H. Rassekh, MD, Ara A

ESRD Care Within the US Department of Veterans Affairs: A Forward-Looking Program With an Illuminating Past Suzanne Watnick, MD, Susan T. Crowley, MD

Opioids in Butte County

Pharmacist-to-prescriber intervention to close therapeutic gaps for statin use in patients with diabetes: A randomized controlled trial Hannah M. Renner,

A nationwide pharmacy chain responds to the opioid epidemic

Pharmacy-based statewide naloxone distribution: A novel “top-down, bottom-up” approach Kate J. Morton, Brianna Harrand, Carly Cloud Floyd, Craig Schaefer,

Brenda G. Clark, PhD, Robert J

Communication in Drug Development: “Translating” Scientific Discovery

Prevention of Anaphylaxis: The Role of the Epinephrine Auto-Injector

The pharmacist's role in overdose: Using mapping technologies to analyze naloxone and pharmacy distribution Allison Burrell, Laken Ethun, Jaime Allen.

The Role of Quality Improvement and Patient Safety in Academic Promotion: Results of a Survey of Chairs of Departments of Internal Medicine in North America

Clinical Management of Food Allergy

The pharmacist role in the development and implementation of a naloxone prescription program in Alabama Jordan L. Wulz, Hanna Sung, B. DeeAnn Dugan,

Implementing take-home naloxone in an urban community pharmacy

Airway Stenting for Patients With Benign Airway Disease and the Food and Drug Administration Advisory Lund Mark E. , MD, FCCP, Force Seth , MD, FCCP

Challenges to the Therapeutic Pipeline for Irritable Bowel Syndrome: End Points and Regulatory Hurdles Michael Camilleri, Lin Chang Gastroenterology

Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study Michael A Irvine,

Autumn Stewart, Kelsey J. Zborovancik, Kara L. Stiely

Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary.

Pharmacists’ role in opioid overdose: Kentucky pharmacists’ willingness to participate in naloxone dispensing Patricia R. Freeman, Amie Goodin, SuZanne.

Evaluation of Food Allergy in Patients with Atopic Dermatitis

A Comparison of Patient and Staff Attitudes About Emergency Department–Based HIV Testing in 2 Urban Hospitals Carrie R. Hecht, MD, Michael D. Smith,

Role of pharmacist led home medication review in community setting and the preparation of medication list Dilip Chandrasekhar, Elizabeth Joseph, Farzana.

Aortic root replacement with cryopreserved homograft for infective endocarditis in the modern North American opioid epidemic Ibrahim Sultan, MD, Valentino.

Severe Constipation Clinical Gastroenterology and Hepatology

Chase D.A. Kooyman, Matthew J. Witry

Jonathan Penm, Neil J. MacKinnon, Jill M

Todd Michael Tartavoulle, CNS-BC The Journal for Nurse Practitioners

Perspectives of athletes and pharmacists on pharmacist-provided sports supplement counseling: An exploratory study Mitchell S. Howard, Kristen L. DiDonato,

Lean Thinking in Emergency Departments: A Critical Review

Position of the American Dietetic Association: Functional Foods

Addressing primary nonadherence: A collaboration between a community pharmacy and a large pediatric clinic Meghan L. Hackerson, Heidi R. Luder, Andrew.

Courtenay Gilmore Wilson, Franklin Rodriguez, Anne C. Carrington, E

Practice Notes from the AAAAI

Emma Palmer, Steve Hart, Patricia R. Freeman

Chronic Diarrhea Clinical Gastroenterology and Hepatology

Table of contents The Journal for Nurse Practitioners

Position of the American Dietetic Association: Vegetarian Diets

The Clinical Implications of Cytochrome P450 Interactions With Opioids and Strategies for Pain Management Michael J. Brennan, MD Journal of Pain and.

Cheryl Genord, Timothy Frost, Deeb Eid

Journal of Vascular Surgery Volume 34, Issue 6, Pages (December 2001)

Jann B. Skelton, Mitchel C. Rothholz, Parisa Vatanka

Table of contents The Journal for Nurse Practitioners

A National Survey to Evaluate Graduate Medical Education in Disparities and Limited English Proficiency: A Report From the AAIM Diversity and Inclusion.

Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend G. Michael Deeb, MD, John Carroll, MD The Journal.

This Month in AJKD American Journal of Kidney Diseases

Practice Notes from the AAAI

Journal-Based CME Evaluation and Application

The future of cardiac surgery training: A survival guide

Direct Observation of Residents: A Model for an Assessment System

Using Indian Health Service (IHS) counseling techniques in an independent community pharmacy to improve adherence rates among patients with diabetes,

Clinical effectiveness of laparoscopic fundoplication in a U. S

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

The development and feasibility of a pharmacy-delivered opioid intervention in the emergency department Erin L. Winstanley, Rebecca Mashni, Sydney Schnee,

Presentation transcript:

Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration’s national program Elizabeth M. Oliva, Melissa L.D. Christopher, Daina Wells, Mark Bounthavong, Michael Harvey, Julianne Himstreet, Thomas Emmendorfer, Michael Valentino, Mariano Franchi, Francine Goodman, Jodie A. Trafton Journal of the American Pharmacists Association Volume 57, Issue 2, Pages S168-S179.e4 (March 2017) DOI: 10.1016/j.japh.2017.01.022 Copyright © 2017 Terms and Conditions

Figure 1 Veterans Health Administration (VHA) Opioid Overdose Education and Naloxone Distribution (OEND) program timeline. The steps referred to in the timeline are described in detail in Table 1. In brief, the steps are: (1) identify clinical champion(s) for OEND implementation, (2) identify target patient populations, (3) garner support and prepare materials and resources and proposals and protocols, (4) obtain any necessary approvals to implement OEND, (5) train staff on OEND, (6) implement OEND, and (7) evaluate OEND. Journal of the American Pharmacists Association 2017 57, S168-S179.e4DOI: (10.1016/j.japh.2017.01.022) Copyright © 2017 Terms and Conditions

Figure 2 Veterans Health Administration (VHA) naloxone prescription options. The intramuscular and intranasal naloxone kits developed by VHA were replaced with corollary Food and Drug Administration–approved devices when they became available (e.g., the auto-injector replaced the intramuscular naloxone kit and the nasal spray replaced the intranasal naloxone kit). Journal of the American Pharmacists Association 2017 57, S168-S179.e4DOI: (10.1016/j.japh.2017.01.022) Copyright © 2017 Terms and Conditions

Figure 3 Number of naloxone prescriptions dispensed and number of new prescribers per quarter. Journal of the American Pharmacists Association 2017 57, S168-S179.e4DOI: (10.1016/j.japh.2017.01.022) Copyright © 2017 Terms and Conditions

Appendix 1 VHA National OEND SharePoint site. Journal of the American Pharmacists Association 2017 57, S168-S179.e4DOI: (10.1016/j.japh.2017.01.022) Copyright © 2017 Terms and Conditions

Appendix 2 VHA Academic Detailing OEND Campaign Homepage. Journal of the American Pharmacists Association 2017 57, S168-S179.e4DOI: (10.1016/j.japh.2017.01.022) Copyright © 2017 Terms and Conditions

Appendix 3 VHA naloxone distribution by state (9/14/16). Journal of the American Pharmacists Association 2017 57, S168-S179.e4DOI: (10.1016/j.japh.2017.01.022) Copyright © 2017 Terms and Conditions

Appendix 4 STORM Look-Up Report with Recommendations on an Example Actionable Patient. Journal of the American Pharmacists Association 2017 57, S168-S179.e4DOI: (10.1016/j.japh.2017.01.022) Copyright © 2017 Terms and Conditions

Appendix 5 Pilot Naloxone Reversal Report. Journal of the American Pharmacists Association 2017 57, S168-S179.e4DOI: (10.1016/j.japh.2017.01.022) Copyright © 2017 Terms and Conditions